Ganciclovir and foscarnet possess substantial activity against cytomegalovirus. Both exhibit dose-limiting toxicity, which reduces their clinical usefulness. We demonstrated synergistic inhibition of cytomegalovirus replication in vitro by ganciclovir and foscarnet. Reduced-dose combination therapy may provide a means to treat patients with cytomegalovirus infection while reducing drug toxicity.
CITATION STYLE
Manischewitz, J. F., Quinnan, G. V., Lane, H. C., & Wittek, A. E. (1990). Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitro. Antimicrobial Agents and Chemotherapy, 34(2), 373–375. https://doi.org/10.1128/AAC.34.2.373
Mendeley helps you to discover research relevant for your work.